The combination of Ypsomed’s connected devices and Philips’ (NYSE:PHG) cloud-based digital platform will allow Ypsomed’s pharmaceutical customers to deliver value-added services aimed at improving patient outcomes, the companies said in a joint statement. They intend to sign the definitive agreements in the fourth quarter of 2018.
Ypsomed describes its SmartServices as a new turnkey digital solution for medication adherence monitoring and smart device management. Philips’ HealthSuite digital platform provides tools and services focused on ease-of-integration, digital lifecycle management, and end-to-end security, according to that company.
Ypsomed makes injections pens, autoinjectors and infusion systems to administer liquid drugs. The new digital services aim to address a wide range of device-oriented challenges and support self-medication services for patients across chronic disease states, such as diabetes, multiple sclerosis, and rheumatoid arthritis.
“Our partnership with Philips aims at embedding smart devices in a digital health ecosystem that simplifies access to therapy-relevant medication adherence data,” said Ulrike Bauer, senior vice president of Ypsomed Delivery Systems, in the statement. “This will allow our pharmaceutical customers to focus on building therapy-specific digital solutions for patients, caregivers, and physicians.”
Integrating Ypsomed’s smart devices and data into HealthSuite will enable pharma companies to achieve shorter time-to-market, scale-up solutions in a secure HIPAA-compliant way, and integrate data from Ypsomed devices with other data sources to support other value-added use cases, said Philips’ HealthSuite business leaderDale Wiggins.
DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.
Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry.
Use code LASTCHANCE to save an additional 20%.